Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine Submucosal Injection for NMIBC
NCT07198451Phase 3Not yet recruiting
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Oct 2025
- Primary completion
- May 2028
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of gemcitabine in Non-muscle-invasive bladder cancer (NMIBC), sponsored by Shanghai University of Traditional Chinese Medicine. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
gemcitabine
03
Conditions
Non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT07198451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07198451.